Abstract

Caffeine citrate, as one type of methylxanthine, is often used to treat apnea in premature infants.Recent studies have found that it is not only used for extubation before weaning, shortening the time of mechanical ventilation, preventing apnea and reducing the occurance of intermittent hypoxic episodes, but also exerting lung protection by inhibiting inflammatory reactions, mitigating oxidative stress, improving pulmonary function and pulmonary angiogenesis.Thus, it could effectively reduce the risk of bronchopulmonary dysplasia in premature infants. Key words: Caffeine; Bronchopulmonary dysplasia; Preterm

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.